Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06946563 · ClinicalTrials.gov registry record

Fetoscopic Neural Tube Defect Repair

A clinical trial of Spina Bifida and Neural Tube Defects, sponsored by Oregon Health and Science University.

Recruiting
Registry status
25
Enrollment target
1
Study location

NCT06946563 is a study of Spina Bifida and Neural Tube Defects that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 25 participants, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06946563, a study of Spina Bifida and Neural Tube Defects, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, post-operative, delivery, and neonatal outcomes will be collected.

Interventions

  • DEVICE Fetoscopic Neural Tube Defect Repair Devices

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-04-01
Est. Completion 2033-04

What the Registry Record Tells You About NCT06946563

The ClinicalTrials.gov registry entry for NCT06946563 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (51% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic Neural Tube Defect Repair Devices is the first listed.

NCT06946563 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06946563 about?

NCT06946563 is a clinical study titled "Fetoscopic Neural Tube Defect Repair". This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, pos...

What is the current status of trial NCT06946563?

This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2023-04-01. Estimated completion is 2033-04.

What conditions does trial NCT06946563 study?

This clinical trial studies the following conditions: Spina Bifida, Neural Tube Defects.

What interventions are being tested in trial NCT06946563?

The interventions under investigation include: Fetoscopic Neural Tube Defect Repair Devices (DEVICE).

Who is sponsoring clinical trial NCT06946563?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06946563 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spina Bifida

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.